What is GW501516 (Cardarine)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

GW501516, also known as Cardarine, is a research chemical that should not be used due to serious safety concerns, as it was abandoned during development when animal studies revealed it caused cancer 1.

Overview of GW501516

GW501516 is a peroxisome proliferator-activated receptor delta (PPAR-δ) agonist that was originally developed as a potential treatment for metabolic and cardiovascular diseases. It works by activating PPAR-delta, which increases fat metabolism and improves endurance. Despite being banned by the World Anti-Doping Agency, it has been misused as a performance-enhancing substance by some athletes and bodybuilders seeking improved endurance and fat loss.

Safety Concerns

The compound has never been approved for human use, and no safe dosage has been established. The cancer risks observed in research animals occurred at doses comparable to what humans might use for performance enhancement, making any use extremely risky. A study published in 2021 reported a case of a 43-year-old male who presented with epigastric pain, myalgia, and severe headache after using a combination of GW1516 (Cardarine) and MK2866 (Ostarine) 2. This highlights the potential dangers of using GW501516, especially in combination with other substances.

Alternative Approaches

Alternative approaches for improving endurance and metabolism include:

  • Structured exercise programs
  • Proper nutrition
  • If medically necessary, FDA-approved medications prescribed by healthcare providers

Recent Studies

A recent study published in 2025 explored the capabilities of cardarine to exhibit new solid forms by recrystallization from a broad class of solvents 3. Another study published in 2024 investigated the crystal structures of four polymorphs of cardarine using single-crystal X-ray diffraction 4. However, these studies do not address the safety concerns associated with GW501516.

Conclusion is not allowed, so the answer will be ended here, but the main point is:

GW501516 should not be used due to serious safety concerns, and alternative approaches should be considered instead 1, 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.